Agenda

ASCO Direct highlights logo

Time Title speaker, Institution
8:30 – 8:35 a.m. Welcome Remarks Jonathan D. Licht, M.D., University of Florida
IMMUNOTHERAPY PRINCIPLES
8:35 – 9:05 a.m. Role of Microbiota in Immunotherapy Response and Toxicity Christian Jobin, Ph.D., University of Florida
9:05 – 9:35 a.m. New Advances In Vaccines & Adoptive Cellular Therapies Duane Mitchell, M.D., Ph.D., University of Florida
9:35 – 9:50 a.m. Q&A
CLINICAL UPDATES & RECENT IMMUNO-ONCOLOGY APPROVALS
9:50 – 10:05 a.m. Recent Approvals and Clinical Updates for Immuno-Oncology in Neuro & Pediatrics Elias Sayour, M.D., Ph.D., University of Florida
10:05 – 10:20 a.m. Recent Approvals and Clinical Updates for Car-T Cell Therapy Jack W. Hsu, M.D., University of Florida
10:20 – 10:50 a.m. Recent Approvals and Clinical Updates for Immuno-Oncology in Breast Cancer Leisha A. Emens, M.D., Ph.D., University of Pittsburgh Cancer Center
10:50 – 11:05 a.m. Q&A
11:05 – 11:20 a.m. Recent Approvals and Clinical Updates for Immuno-Oncology in Gynecologic Cancers Martina Murphy, M.D., University of Florida
11:20 – 11:35 a.m. Recent Approvals and Clinical Updates for Immuno-Oncology in Genitourinary Cancers Jonathan A. Chatzkel, M.D., University of Florida
11:35 – 11:50 a.m. Recent Approvals and Clinical Updates for Immuno-Oncology in Gastrointestinal Cancers Sherise Rogers, M.D., M.P.H., University of Florida
11:50 – 12:20 p.m. Recent Approvals and Clinical Updates for Immuno-Oncology in Lung and Head & Neck Cancers Devika Das, M.D., The University of Alabama at Birmingham
12:20 – 12:35 p.m. Q&A
12:35 – 1 p.m. Lunch
TOXICITY MANAGEMENT AND SPECIAL POPULATIONS
1 – 1:30 p.m. Management of Acute and Chronic Immune Reactions Brian H. Ramnaraign, M.D., University of Florida
1:30 – 2 p.m. Immuno-Oncology Management in Special Populations: Autoimmune Diseases; Poor Performance Status; Elderly and Diabetic Patients; Covid19 Positive Patients Panel Discussion moderated by: David DeRemer, Pharm.D., BCOP with: Brian H. Ramnaraign, M.D., Zeina A. Al-Mansour, M.D., Dennie Jones, Jr, M.D., University of Florida
FUTURE DIRECTIONS
2 – 2:30 p.m. Rational Approaches and Future Directions in Immuno-Oncology Therapies Samir N. Khleif, M.D., Georgetown University Cancer Center
2:30 – 2:45 p.m. Q&A
2:45 – 2:50 p.m. Closing Remarks Jonathan D. Licht, M.D., University of Florida